Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: results from the observational retrospective-prospective RUBINO study. - Bazzichi L; Biasi D; Tinazzi E; Muratore M; Pellerito R; Russo R; Corsaro Santi M; De Sandre P; Epis O; Granata M; Kroegler B; Meschini C; et al. (Reumatismo, 2014)